NeuClone has retained licence to the jointly developed biosimilars for the developed markets of USA, Europe, Canada, Australia, Taiwan. MELBOURNE: Sydney based biotechnology company NeuClone has inked a licensing agreement and joint development partnership ... Economic Times, 2 weeks ago
Biotech start-up signs deal with Indian giant - Individual.com, 1 day ago
Serum Institute teams up with Australian biotech firm - Hindu Business Line, 2 weeks ago
Cyrus Poonawalla, chairman, Serum Institute of India, is set to increase his bid for the iconic Grosvenor House hotel property in London to close to $935 million after the present owner Sahara group has put it on the block to meet its liquidity ...Sify, 2 days ago Vaccine Billionaire Cyrus Poonawalla Joins Race For London's Grosvenor House Hotel Forbes.com, 6 days ago
Owners of Pune-based Serum Institute of India, the Poonawalla's have thrown the hat to acquire the iconic Grosvenor Hotel in UK from Sahara Group. Adar Poonawalla, CEO of Serum Institute and son of Cyrus Poonawalla is categorical that they are only ...Smart Investor, 1 day ago 'I doubt if Sahara is serious about selling properties' Rediff.com, 1 day ago
(MarketLine via COMTEX News Network) -- Xenetic Biosciences, Inc., a biopharmaceutical company, has announced that its partner, the Serum Institute of India, has dosed first patient in the second cohort of a Phase IIa clinical, sequential single ...PredictWallStreet, 1 month ago
Global Meningococcal Vaccines Market - Forecasts to 2019: Sanofi, Novartis, GlaxoSmithKline, Pfizer, Serum Institute of India, JN-International, Nuron, Baxter and Biomed
/PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/rd8s6p/meningococcal ) has announced the addition of the " " report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Meningococcal disease ...OSIX News, 2 months ago
Findings from Serum Institute of India in the Area of Vaccines Reported (Structure function attributes of gold nanoparticle vaccine association:...
Findings from Serum Institute of India in the Area of Vaccines Reported (Structure function attributes of gold nanoparticle vaccine association: Effect of particle size and association temperature) By a News Reporter-Staff News Editor at Vaccine ...HispanicBusiness.com, 12 hours ago
US-based biopharmaceutical firm Xenetic Biosciences has announced that its partner, the Serum Institute of India, has started dosing patients in the second group of a Phase IIa clinical, sequential single dose trial of intravenously (IV) ...Pharmaceutical Business Review, 1 month ago
In a breather to Orchid Chemicals & Pharmaceuticals, the Company Law Board has dismissed an application filed by Serum Institute of India, seeking an interim injunction on Orchid's debt recast and a business transfer deal with Hospira India. ...Hindu Business Line, 2 months ago ORCHID CHEMICALS & PHARMACEUTICALS : Breather for orchid as clb refuses to stay debt recast 4 Traders, 2 months ago
The interim order was issued on an application filed by Serum Institute, Cyrus Poonawalla and his firms BS Reporter | Chennai May 22, 2014 Last Updated at 23:32 IST The southern regional bench of the Company Law Board (CLB) has dismissed a request ...Business Standard India, 2 months ago
The Southern Regional Bench of Company Law Board (CLB) has issued an order dismissing a request of billionaire Cyrus Poonawalla and his firms seeking an injunction restraining Orchid Chemicals and Pharmaceuticals Ltd from implementing its Corporate ...Business Standard India, 2 months ago
on your WebpageAdd Widget >Get your members hooked!